Non-Opioid Pain Treatment Market Ongoing Trends And Recent Developments | Medropharm Gmbh, US Worldmeds LLC, Centrexion Therapeutics Corp., Tilray, Inc.

Global Non-Opioid Pain Treatment Market is valued at approximately USD 13.8 million in 2019 and is anticipated to grow with a healthy growth rate of more than 18% over the forecast period 2020-2027.

The latest report pertaining to Non-Opioid Pain Treatment Market provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.

Get Sample Copy of This Premium Report @

*The sample pages of this report is immediately accessible on-demand.**

Market Analysis of Non-Opioid Pain Treatment –

Non-opioid pain treatment is the complementary to the opioids treatment which are increasingly used for the mild to moderate pain. Non opioids pain treatment is regularly taken with or without remedy that is over the counter (OTC) drugs. This treatment method are often robust pain relievers. They typically opt in the place of opioids due to its increase addiction triggered by opioids. For acute pain, non-opioid drugs are ideal to provide effective health benefits and first-line treatment and are available in over the counter and prescription formulations. This has led to a rise in demand for non-opioid treatment all over the world.

Moreover, the increasing prevalence of chronic diseases such as cancer in the developed & developing countries, along with the rising research and developmental (R&D) efforts associated with non-opioid treatment for pain relief are few other factors responsible for the market growth over the forecast period. As per the International Agency for Research on Cancer (IARC), around 17.0 million new cancer cases were registered in 2018, with overall 9.5 million cancer deaths around the world. As per the IARC, the global prevalence of cancer is also expected to grow to over 27.5 million new cancer cases and 16.3 million cancer deaths by the year 2040.

The regional analysis of the global Non-Opioid Pain Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the undergoing clinical trials and funding for R&D of novel drug therapies, along with the presence of significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of chronic diseases, along with the changing economic demographic which improve drug affordability would create lucrative growth prospects for the Non-Opioid Pain Treatment market across the Asia-Pacific region.

Major market player included in this report are:

Medropharm Gmbh

US Worldmeds LLC

Centrexion Therapeutics Corp.

Tilray, Inc.

GW Pharmaceuticals, plc

Allergan plc

Cronos Group

Medical Marijuana, Inc.

Cara Therapeutics, Inc.

Canopy Growth Corporation

The detailed segments and sub-segment of the market are explained below:

By Product:

Medical Cannabis


Omega 3 Fatty Acid-Containing

Botulinum Toxins


By Application:

Orthopaedic and Musculoskeletal Pain

Neuropathic Pain

Cancer Pain


By Region:

North America










Asia Pacific





South Korea


Latin America



Rest of the World 

Get Full information of This Report@

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at:

Article:  Blog:

 Blog:   Blog: 

Blog:  Website: